Train of Four Monitoring for Neuromuscular Blockade

Train of four is a nerve stimulation pattern used during and after surgery to measure how deeply a patient’s muscles are paralyzed by the drugs given to keep them still on the operating table. Four quick electrical impulses are delivered to a nerve, and clinicians count how many muscle twitches result and how strong each one is compared to the last. The pattern was designed in 1970 specifically so that anesthesia teams could gauge paralysis without needing a baseline measurement taken before the muscle relaxant was given.¹ It remains the most widely used neuromuscular monitoring method in operating rooms and intensive care units worldwide, and understanding what its numbers mean has real consequences for patient safety.

What the Four Twitches Tell You

A peripheral nerve stimulator sends four electrical pulses, each separated by half a second, to a motor nerve. In a person with no muscle relaxant on board, all four twitches will be roughly equal in strength. When a non-depolarizing neuromuscular blocking drug is circulating, the fourth twitch weakens before the first does. This progressive weakening across the four twitches is called “fade,” and it is the signature the anesthesia team is looking for. The degree of fade, expressed as a ratio of the fourth twitch’s strength to the first, is the train-of-four ratio, or TOF ratio. A ratio of 1.0 means no fade at all. A ratio of 0.5 means the fourth twitch is half as strong as the first.

Eventually, as the drug’s effect deepens, twitches start to disappear entirely. First the fourth twitch vanishes, then the third, then the second, until finally even the first twitch is gone. Clinicians track this as the TOF count: how many of the four twitches are still detectable. A count of zero means no visible response at all, indicating profound paralysis. The count and the ratio together map onto a spectrum of block depth that guides nearly every dosing decision during surgery.

Levels of Block and Why They Matter

Anesthesia teams classify neuromuscular block into several levels based on what the TOF monitor shows. Complete block (no response even to specialized stimulation) and deep block (some response to post-tetanic stimulation but a TOF count of zero) are reserved for procedures requiring full relaxation of the diaphragm, larynx, or upper abdominal muscles. Moderate block, defined as a TOF count of one to three visible twitches, is generally enough to keep a patient immobile for most surgeries as long as anesthesia depth is adequate.²

Once the fourth twitch reappears, the block is classified as either shallow (TOF ratio below 0.4) or minimal (TOF ratio between 0.4 and 0.9).³ The threshold that matters most at the end of surgery is a TOF ratio of 0.9 or higher. Below that level, a patient’s airway protective reflexes and breathing muscles may not be fully recovered, even if they look awake and can follow commands. Getting to that 0.9 threshold before removing the breathing tube is one of the central goals of neuromuscular monitoring.

Where on the Body It Is Measured

The most common monitoring site is the ulnar nerve at the wrist, with the resulting thumb twitch (from the adductor pollicis muscle) measured or felt by the clinician. This site has become the standard partly because the thumb is easy to observe and partly because it tends to recover more slowly than other muscles, making it a conservative gauge. If the thumb is back to normal, the airway muscles are almost certainly fine too.

Other sites are sometimes used when the hand is inaccessible, such as during certain arm surgeries. The orbicularis oculi muscle around the eye, stimulated via the facial nerve, is one alternative. However, studies consistently show that the orbicularis oculi recovers faster than the adductor pollicis, meaning it can look normal while the thumb would still show residual paralysis.⁴ Research in ICU patients found the same pattern: after prolonged infusions of a muscle relaxant, the eye muscle was less sensitive to the drug than the thumb or foot muscles.⁵ Current guidelines specifically recommend monitoring at the adductor pollicis and recommend against relying on the eye muscles for final recovery assessments.⁶

Why Feeling the Twitch Is Not Enough

In many operating rooms around the world, clinicians still assess the TOF by placing their hand on the patient’s thumb and feeling the twitches. This seems intuitive, but it turns out to be dangerously unreliable, especially in the range that matters most for safe extubation. When the mechanographic TOF ratio sat between 0.41 and 0.70, visual assessment of the thumb failed to detect fade in nearly half of cases when higher stimulating currents were used.⁷ Tactile assessment was no better, missing fade over half the time in the same range. In practical terms, a clinician feeling the twitches could easily conclude the patient was ready for extubation when significant paralysis remained.

A more recent study put numbers to the direction of this error. When anesthesia clinicians visually assessed the thumb’s response and those assessments were compared against electromyographic measurements, the subjective assessment overestimated the response almost half the time. When subjective and objective readings disagreed, the clinician’s estimate was higher than the instrument’s reading in over 90% of cases.⁸ In other words, clinicians almost never underestimate the block; they consistently think the patient has recovered more than they actually have.

The problem is especially pronounced at intermediate TOF counts (one, two, or three visible twitches). In a study comparing clinician counts to an objective monitor, agreement at counts of zero and four was about 87%, but at counts of one through three agreement dropped to just 36%. Among the disagreements at those intermediate counts, clinicians counted higher than the instrument 96% of the time.⁹ Since dosing of reversal agents depends on the TOF count, overestimating means the patient might get too little reversal drug, or get it too early.

Quantitative Monitoring Technologies

Because subjective assessment is so unreliable, the field has moved toward objective devices that assign a number to each twitch. Three main technologies exist: mechanomyography, which directly measures muscle force; acceleromyography, which measures the acceleration of the thumb’s movement; and electromyography, which records the electrical signal in the muscle itself. Mechanomyography was long considered the gold standard, but the devices are bulky and impractical for routine clinical use.

Acceleromyography became the workhorse of clinical monitoring because the devices are small and easy to attach. However, acceleromyographic devices frequently produce TOF ratio values above 1.0, which should be impossible but occurs because of the way thumb acceleration is measured. One comparison found that about 23% of acceleromyographic readings exceeded 1.0, compared with only 2 to 4% for electromyography or mechanomyography.¹⁰ This quirk complicates interpretation: when the device says 0.95, is the patient truly recovered, or is the number inflated? Electromyographic devices, by contrast, most closely resemble mechanomyography and produce fewer problematic readings.¹¹

When counting twitches rather than measuring ratios, the picture shifts slightly. A study comparing palpation to all three technologies found that electromyography agreed best with what clinicians could feel by touch, while acceleromyography often underestimated the count, reporting fewer twitches than a clinician would feel.¹² The practical takeaway is that no single device is perfect, and understanding the biases of whichever technology you are using matters for making safe decisions.

Residual Block and Lung Complications

The reason all this monitoring precision matters comes down to what happens when paralysis lingers after surgery. Residual neuromuscular block, meaning the patient’s muscles have not fully recovered by the time they leave the operating room, is a well-documented risk factor for breathing problems in the recovery period.¹³ The muscles of the upper airway and the diaphragm do not need to be dramatically weak for trouble to start. Even modest residual block can impair the ability to cough, clear secretions, or protect the airway from aspiration.

A landmark prospective study comparing three muscle relaxants found that patients who received pancuronium and arrived in recovery with a TOF ratio below 0.7 developed pulmonary complications at more than three times the rate of those without residual block. The study identified a low TOF ratio, along with abdominal surgery, older age, and lengthy operations, as independent risk factors for these complications.¹⁴ This evidence is a major reason the accepted recovery threshold has shifted from a TOF ratio of 0.7 to 0.9 over the past two decades. Sensitivity analyses suggest that routine quantitative TOF monitoring across a hospital would actually save money overall by reducing these complications.¹⁵

Reversing the Block

At the end of surgery, most patients receive a reversal agent to speed recovery from the muscle relaxant. The two main options are neostigmine, which has been used for decades, and sugammadex, a newer drug that works by a completely different mechanism. The TOF reading at the moment of reversal determines which drug to use and at what dose.

Neostigmine works best when the block has already started to wear off. Research suggests that the ideal moment for neostigmine administration is when a faint first twitch has reappeared; giving it during deeper block prolongs the reversal process.¹⁶ Even under favorable conditions, neostigmine has a ceiling effect. At a TOF ratio of around 0.2 (meaning the block has partially recovered but is still substantial), neostigmine was unable to reliably bring patients to a TOF ratio of 0.9 within a reasonable time frame.¹⁷ A study of shallow block confirmed that a neostigmine dose of 40 micrograms per kilogram was the most effective at reducing recovery time, but even at that dose, recovery took longer after cisatracurium than rocuronium.¹⁸

Sugammadex works by directly encapsulating the muscle relaxant molecule (specifically rocuronium or vecuronium), pulling it away from the nerve-muscle junction. It can reverse deeper levels of block and does so faster. At a TOF count of four, sugammadex at 1.0 mg/kg brought patients to a normalized TOF ratio of 0.9 or higher in about four and a half minutes, while 2.0 mg/kg achieved it in under three minutes. Neostigmine at the same recovery point took over eleven minutes and only succeeded in about three quarters of patients.¹⁹ At deeper levels of block, sugammadex maintained its speed advantage. A dose-finding study estimated that roughly 0.5 mg/kg of sugammadex could reverse a TOF ratio of 0.2 to a ratio of 0.9 within about ten minutes for nearly all patients.²⁰ Separate research on vecuronium-induced block at a TOF ratio of 0.3 reached a similar conclusion: sugammadex provides faster, more reliable reversal than neostigmine even in shallow residual block.²¹

How Depolarizing Drugs Change the Pattern

Everything described so far applies to non-depolarizing muscle relaxants like rocuronium, vecuronium, and cisatracurium, which are the drugs used in the vast majority of modern surgeries. The one commonly used depolarizing agent, succinylcholine, behaves differently on TOF monitoring. In its initial phase (Phase I), succinylcholine causes all four twitches to weaken equally without fade, because the drug mimics acetylcholine and keeps the receptor channel open rather than blocking it. As long as the block stays in Phase I, the four twitches shrink together, and the TOF ratio stays near 1.0.

With prolonged or repeated exposure to succinylcholine, the block character shifts to Phase II, which begins to look like a non-depolarizing block. Fade appears, the TOF ratio drops below about 0.3, and the block becomes harder to predict.²² The emergence of fade on TOF monitoring during succinylcholine use is a recognized marker that Phase II block has developed.²³ This distinction matters because Phase II block may respond to reversal agents in a way Phase I does not, and its onset signals that the clinical situation has become less predictable.

Why Fade Happens

For years the textbook explanation was that fade was a purely “prejunctional” phenomenon, meaning it was caused by muscle relaxants blocking receptors on the nerve terminal that help sustain acetylcholine release during repeated stimulation. That explanation is incomplete. Research using toxins with highly specific targets showed that blocking acetylcholine release at the nerve terminal decreased overall twitch strength but did not, by itself, produce fade. Reducing the number of available receptors on the muscle side alone did produce fade. Blocking the prejunctional receptors only caused fade when the safety margin of neurotransmission was already reduced by a simultaneous postjunctional effect.²⁴ In plain language, fade during TOF stimulation reflects a thinning of the safety margin at the nerve-muscle junction, which can come from the muscle side, the nerve side, or both. This is more than an academic detail: it explains why different drugs produce different fade patterns, and why the TOF ratio does not behave identically across all blocking agents.

Temperature and Other Confounding Factors

Peripheral temperature is the most clinically relevant variable that can throw off TOF readings. During long surgeries, the patient’s extremities often cool down, especially if warming measures are inadequate. Once skin temperature at the monitored hand drops below about 32°C, the twitch response starts to change. At a hand skin temperature of 27°C, one study found roughly a 20% reduction in twitch strength and a 10% decrease in the TOF ratio, with considerable variation between patients.²⁵ Above 32°C, the readings stayed stable.

Hypothermia also changes the apparent duration of a muscle relaxant’s effect. When one arm was cooled and the other kept warm in the same patient, vecuronium’s duration of action in the cold arm was about 60% longer, and recovery time roughly doubled.²⁶ The post-tetanic count, a deeper-block assessment, also became unreliable in the cold arm, losing its usual correlation with recovery timing. The practical implication is straightforward: keep the monitored hand warm, or recognize that cold-hand readings will make the block look deeper and longer than it truly is centrally.

Stimulating current intensity also matters, particularly in awake or lightly sedated patients. In conscious subjects, research found that 30 milliamps was the sweet spot for TOF monitoring: currents below that (20 milliamps) delayed the apparent return of twitches during recovery, making the block look deeper than it was, while higher currents (50 to 60 milliamps) did not improve accuracy but caused significantly more pain.²⁷

Double Burst Stimulation and Post-Tetanic Count

Train of four is not the only stimulation pattern available. When clinicians need to detect subtle residual block that TOF might miss on manual assessment, double burst stimulation (DBS) delivers two short bursts of high-frequency impulses separated by a pause. The idea is that comparing two groups of fused twitches is easier for the human hand to detect than comparing four individual twitches. Research supports this: in the TOF ratio range of 0.41 to 0.70, visual assessment missed TOF fade in 46% of cases at standard current, but missed DBS fade in only 18%.²⁸ DBS does not replace quantitative TOF monitoring, but when only subjective assessment is available, it offers a meaningful improvement in sensitivity.

At the other end of the spectrum, when the block is so deep that no TOF twitches are visible at all, the post-tetanic count (PTC) becomes the relevant measurement. A tetanic stimulus (a sustained high-frequency burst) briefly floods the junction with acetylcholine, and the clinician then counts how many single twitches appear afterward. The PTC provides a rough estimate of how long until the first TOF twitch will return. Studies have confirmed that DBS responses appear earlier than TOF responses during recovery from deep block: in one study, a single palpable DBS response emerged at a median post-tetanic count of about seven, implying still-profound paralysis.²⁹

Monitoring in the ICU

Outside the operating room, muscle relaxants are sometimes infused for hours or days in critically ill patients, particularly those with severe respiratory failure who need to be kept perfectly still on the ventilator. TOF monitoring in this setting carries its own challenges. A multicenter observational study of ICU patients receiving continuous neuromuscular blocking agents found an unexpected pattern: patients who were monitored with TOF actually had longer infusion durations than those who were not. The authors cautioned that this was likely due to selection bias (sicker patients were more likely to get monitoring) and potentially to a behavioral effect where TOF readings prompted more frequent dose adjustments that paradoxically prolonged drug exposure.³⁰ This does not mean monitoring is harmful, but it does highlight that how clinicians respond to the numbers matters as much as the numbers themselves.

Monitoring site choice also shifts in the ICU. The arm may be edematous, positioned awkwardly, or have intravenous lines running through it. The same site-sensitivity differences seen in surgical patients hold: the orbicularis oculi can give falsely reassuring results, and the adductor pollicis or plantar flexor muscles at the ankle remain more reliable.³¹

Neonates and Infants

The developing nervous system in very young patients adds another layer of complexity. Neuromuscular transmission in neonates and small infants is immature until roughly two months of age. This means a healthy newborn might naturally have a slightly reduced TOF ratio without ever having received a muscle relaxant. One investigation into prolonged recovery from neuromuscular blockade in the neonatal ICU noted this developmental immaturity and suggested it could contribute to the variability seen in how quickly infants recover from these drugs.³² Interpreting TOF values in this population therefore requires extra caution, because a low ratio may not mean the same thing it would in an adult.